. Author manuscript; available in PMC: 2011 Feb 28.

Published in final edited form as: Cancer Chemother Pharmacol. 2009 Mar 26;64(6):1149–1155. doi: 10.1007/s00280-009-0977-x

Table 1.

Dose escalation scheme

Dose level	GTI-2040 (mg/kg per day)	Capecitabine (mg/m² per BID)	Oxaliplatin (mg/m²)
−1	3	600	100
1	3	600	130
2^a

Due to dose-limiting toxicities at dose level 1, planned increases in GTI-2040 and capecitabine were not tested